These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 8190019)
1. Effect of combination interleukin-1 and erythropoietin in ameliorating the hematopoietic toxicity associated with the use of zidovudine administered to normal mice. Gallicchio VS; Hughes NK; Tse KF; Gaines H Life Sci; 1994; 54(20):PL351-61. PubMed ID: 8190019 [TBL] [Abstract][Full Text] [Related]
2. Prevention of hematopoietic myeloid and megakaryocyte toxicity associated with zidovudine in vivo in mice with recombinant GM-CSF. Gallicchio VS; Hughes NK; Tse KF Growth Regul; 1994 Jun; 4(2):41-7. PubMed ID: 7950902 [TBL] [Abstract][Full Text] [Related]
3. Effect of interleukin-1, GM-CSF, erythropoietin, and lithium on the toxicity associated with 3'-azido-3'-deoxythymidine (AZT) in vitro on hematopoietic progenitors (CFU-GM, CFU-MEG, and BFU-E) using murine retrovirus-infected hematopoietic cells. Gallicchio VS; Hughes NK; Hulette BC; Noblitt L J Leukoc Biol; 1991 Dec; 50(6):580-6. PubMed ID: 1940611 [TBL] [Abstract][Full Text] [Related]
4. Effect of combination interleukin-3 (IL-3) and granulocyte-macrophage colony stimulating factor (GM-CSF) on hematopoiesis administered to retrovirus-infected immunodeficient mice receiving dose-escalation zidovudine (AZT). Gallicchio VS; Hughes NK; Tse KF; Ling J; Gaines H; Bowen TE; Uluitu M Int J Immunopharmacol; 1995 Nov; 17(11):865-78. PubMed ID: 8788116 [TBL] [Abstract][Full Text] [Related]
5. In-vivo effect of interleukin 3 and erythropoietin, either alone or in combination, on the hematopoietic toxicity associated with zidovudine. Gallicchio VS; Hughes NK; Tse KF Cytokine; 1993 Jan; 5(1):62-71. PubMed ID: 8485306 [TBL] [Abstract][Full Text] [Related]
6. Influence of interleukin-3 (IL-3) on the hematopoietic toxicity associated with combination anti-viral drugs (zidovudine and DDI) in vitro using retrovirus-infected bone marrow cells. Gallicchio VS; Hughes NK Int J Immunopharmacol; 1994 Apr; 16(4):359-66. PubMed ID: 8045675 [TBL] [Abstract][Full Text] [Related]
7. Suppression of murine hematopoiesis in vivo after chronic administration of zidovudine: evidence that zidovudine-induced anemia is the result of decreased bone marrow-derived, erythropoietin-responsive progenitor cells. Gallicchio VS; Hughes NK Proc Soc Exp Biol Med; 1992 Apr; 199(4):459-65. PubMed ID: 1549625 [TBL] [Abstract][Full Text] [Related]
8. Prevention of the hematopoietic toxicity associated with zidovudine in vivo with IL-1 alone or in combination with GM-CSF administered to normal mice. Gallicchio VS; Hughes NK; Tse KF; Gaines H Growth Factors; 1993; 9(3):177-83. PubMed ID: 8274295 [TBL] [Abstract][Full Text] [Related]
9. Additive effect of erythropoietin and heme on murine hematopoietic recovery after azidothymidine treatment. Harrison J; Kappas A; Levere RD; Lutton JD; Chertkov JL; Jiang S; Abraham NG Blood; 1993 Dec; 82(12):3574-9. PubMed ID: 8260696 [TBL] [Abstract][Full Text] [Related]
10. Increased hematopoietic toxicity following administration of interferon-a with combination dideoxynucleoside therapy (zidovudine plus ddI) administered in normal mice. Gallicchio VS; Scott KW; Hughes NK; Tse KF; Gaines H; Kirk PR; Birch NJ Life Sci; 1995; 56(3):PL71-81. PubMed ID: 7823768 [TBL] [Abstract][Full Text] [Related]
11. Comparison of dideoxynucleoside drugs (DDI and zidovudine) and induction of hematopoietic toxicity using normal human bone marrow cells in vitro. Gallicchio VS; Hughes NK; Tse KF Int J Immunopharmacol; 1993 Feb; 15(2):263-8. PubMed ID: 8468123 [TBL] [Abstract][Full Text] [Related]
12. Corticosteroid modulation of interleukin-1 hematopoietic effects and toxicity in a murine system. Rinehart J; Delamater EW; Keville L; Measel J Blood; 1994 Sep; 84(5):1457-63. PubMed ID: 8068940 [TBL] [Abstract][Full Text] [Related]
13. Differential effect of erythropoietin and GM-CSF on megakaryocytopoiesis from primitive bone marrow cells in serum-free conditions. Cardier JE; Erickson-Miller CL; Murphy MJ Stem Cells; 1997; 15(4):286-90. PubMed ID: 9253112 [TBL] [Abstract][Full Text] [Related]
14. Studies on the efficacy of mast cell growth factor (c-kit ligand) in vitro as well as in vivo. Hintz-Obertreis P; Weinmann E; Seiler FR Behring Inst Mitt; 1991 Dec; (90):14-22. PubMed ID: 1724901 [TBL] [Abstract][Full Text] [Related]
15. Acute toxic effects of 3'-azido-3'-deoxythymidine (AZT) on normal and regenerating murine hematopoiesis. Scheding S; Media JE; Nakeff A Exp Hematol; 1994 Jan; 22(1):60-5. PubMed ID: 8282060 [TBL] [Abstract][Full Text] [Related]
16. Influence of interleukin-3 on zidovudine (AZT)-induced in vitro toxicity to human hematopoietic progenitors. Gallicchio VS; Hughes NK Int J Cell Cloning; 1992 Mar; 10(2):99-104. PubMed ID: 1545155 [TBL] [Abstract][Full Text] [Related]
17. Sustained zidovudine treatment on hematopoiesis in immunodeficient mice. Gallicchio VS; Hughes NK; Tse KF Int J Immunopharmacol; 1993 Aug; 15(6):673-81. PubMed ID: 8407052 [TBL] [Abstract][Full Text] [Related]
18. Lithium and anti-viral drug toxicity: II. Further studies on the ability of lithium to modulate the hematopoietic toxicity associated with the anti-viral drug zidovudine (AZT). Kazim S; Townsley L; Hughes NK; Tse KF; Ling J; Scott K; Birch NJ; Gallicchio VS Rom J Physiol; 1993; 30(3-4):231-9. PubMed ID: 7582937 [TBL] [Abstract][Full Text] [Related]